Evidence map›Paper›PMID 32665623›Full record

ArticleCommunications biology2020

Hypoxic microenvironment shapes HIV-1 replication and latency.

Xiaodong Zhuang, Isabela Pedroza-Pacheco, Isabel Nawroth, Anna E Kliszczak, Andrea Magri, Wayne Paes, Claudia Orbegozo Rubio, Hongbing Yang, Margaret Ashcroft, David Mole and 3 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Network Pharmacology-Guided Identification ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. NSC95397 is a Novel HIV-1 Latency Reversing Agent.bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. HIV-1 replication and latency are balanced by mTOR-driven cell metabolism.Frontiers in cellular and infection microbiology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Xiaodong Zhuang *Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
Isabela Pedroza-Pacheco *Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
Isabel NawrothInstitute of Immunity and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Anna E KliszczakNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
Andrea MagriNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
Wayne PaesNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.ORCID http://orcid.org/0000-0002-0529-2765
Claudia Orbegozo RubioNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
Hongbing YangNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
Margaret AshcroftDepartment of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0AH, UK.ORCID http://orcid.org/0000-0002-0066-3707
David MoleNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
Peter BalfeInstitute of Immunity and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.ORCID http://orcid.org/0000-0002-6246-0876
Persephone BorrowNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.ORCID http://orcid.org/0000-0002-3877-9780
Jane A McKeatingNuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK. jane.mckeating@ndm.ox.ac.uk.ORCID http://orcid.org/0000-0002-7229-5886
University of Oxford · GBUniversity of Birmingham · GBUniversity of Cambridge · GB

Funding

Restriction of HIV-1 transmission by type 1 interferonsR01AI114266 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HAHN, BEATRICE H · 2014 to 2018
$3.2M
Cancer Research UK 16016Department of Health NIHR-RP-2016-06-004Medical Research Council G0400802Medical Research Council G0801976Medical Research Council MR/R022011/1NIAID NIH HHS 114266Wellcome Trust 200838/Z/16/Z
6 · The paper itself

Abstract

Viral replication is defined by the cellular microenvironment and one key factor is local oxygen tension, where hypoxia inducible factors (HIFs) regulate the cellular response to oxygen. Human immunodeficiency virus (HIV) infected cells within secondary lymphoid tissues exist in a low-oxygen or hypoxic environment in vivo. However, the majority of studies on HIV replication and latency are performed under laboratory conditions where HIFs are inactive. We show a role for HIF-2α in restricting HIV transcription via direct binding to the viral promoter. Hypoxia reduced tumor necrosis factor or histone deacetylase inhibitor, Romidepsin, mediated reactivation of HIV and inhibiting HIF signaling-pathways reversed this phenotype. Our data support a model where the low-oxygen environment of the lymph node may suppress HIV replication and promote latency. We identify a mechanism that may contribute to the limited efficacy of latency reversing agents in reactivating HIV and suggest new strategies to control latent HIV-1.

Indexed as

Basic Helix-Loop-Helix ProteinsCellular MicroenvironmentEndothelial PAS Domain-Containing Protein 1Flow CytometryHIV-1HumansHypoxiaLymphoid TissueOxygenPromoter Regions, GeneticReal-Time Polymerase Chain ReactionViral TranscriptionVirus ActivationVirus LatencyVirus ReplicationBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Oxygen

Identifiers

PMID32665623
PMCPMC7360605
OpenAlexW3042392407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.